Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 7.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 50.40
  • 52 Week Low: 7.20
  • Currency: UK Pounds
  • Shares Issued: 189.93m
  • Volume: 194,880
  • Market Cap: £14.72m
  • RiskGrade: 348
  • Beta: 1.48

Latest Deals

Traded Action Notifier PriceAmountValue
08-Oct-24 Placing Christopher H B Mills 9.00p 500,000 £45,000.00
07-Oct-24 Sell Christopher H B Mills 8.00p 83,696 £6,695.68

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
08-Oct-24 Placing Christopher H B Mills 9.00p 500,000 £45,000.00
07-Oct-24 Sell Christopher H B Mills 8.00p 83,696 £6,695.68

Director Shareholdings

Notifier Holding Value*
Christopher H B Mills 14,609,946 £1,132,271
James Renwick McCullough 2,746,386 £212,845
Fergus Fleming 569,481 £44,135

Major Shareholders

Notifier** Holding Value*
CVI Holdings, LLC 33,000,000 £2,557,500
Ruffer LLP 28,500,000 £2,208,750
Unicorn Asset Management Limited 18,955,777 £1,469,073
Harwood Capital LLP 14,609,946 £1,132,271
Polar Capital, LLP 13,866,061 £1,074,620
Icahn School of Medicine at Mount Sinai 10,750,926 £833,197
Jefferson River Capital LLC 8,294,932 £642,857
Mount Sinai 8,018,986 £621,471
Gilder Gagnon Howe and Co LLC 6,042,634 £468,304
Forest Nominees Limited 4,001,187 £310,092
Lombard Odier & Co Ltd 2,952,334 £228,806
Amati Global Investors 2,455,247 £190,282
Fidelity Investment International 2,173,851 £168,474

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 7.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 50.40
52 Week Low 7.20
Volume 194,880
Shares Issued 189.93m
Market Cap £14.72m
Beta 1.48
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.53% above the market average17.53% above the market average17.53% above the market average17.53% above the market average17.53% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Price Trend
93.01% below the market average93.01% below the market average93.01% below the market average93.01% below the market average93.01% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Income Not Available
Growth
34.3% below the market average34.3% below the market average34.3% below the market average34.3% below the market average34.3% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average

RENX Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:27 1,000 @ 7.50p
15:02 66,547 @ 7.50p
12:37 82,146 @ 7.20p
12:22 32 @ 7.50p
11:41 5,727 @ 7.50p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page